205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.61%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-80.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-97.57%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-97.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-38.74%
Negative net income growth while LSCC stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-37.50%
Negative EPS growth while LSCC is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-37.50%
Negative diluted EPS growth while LSCC is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-13.82%
Share reduction while LSCC is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-13.82%
Reduced diluted shares while LSCC is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.67%
10Y revenue/share CAGR at 50-75% of LSCC's 54.00%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
39.67%
5Y revenue/share CAGR at 50-75% of LSCC's 54.00%. Martin Whitman would worry about a lagging mid-term growth trajectory.
34.10%
3Y revenue/share CAGR at 50-75% of LSCC's 54.00%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
184.89%
10Y net income/share CAGR of 184.89% while LSCC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
184.89%
Net income/share CAGR of 184.89% while LSCC is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
405.40%
3Y net income/share CAGR of 405.40% while LSCC is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.00%
3Y dividend/share CAGR of 8.00% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.